title: Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.
abstract: We explored the impact of patient demographics, anthropometric measurements, cardiovascular risk factors, and soluble biomarkers on necrotic core and atheroma size in patients with coronary disease. The IBIS-2 trial enrolled 330 patients. In the multivariate analysis, at baseline, creatinine had a positive, whereas baseline mean lumen diameter and myeloperoxidase had a negative, independent association with percentage of necrotic core (PNC); while age, glomerular filtration rate <60, HbA1c, previous PCI or CABG and baseline % diameter stenosis were positively, and acute coronary syndromes (ACS) were negatively associated with baseline percentage atheroma volume (PAV). The variables associated with a decrease in PNC from baseline were darapladib, ACS and a large content of NC at baseline, while variables associated with an increase in PNC were previous stroke and % diameter stenosis at baseline. Those variables associated with a decrease in PAV from baseline were waist circumference, statin use, CD40L and baseline PAV, while the only variable associated with an increase in PAV was baseline diastolic blood pressure. Treatment with darapladib was associated with a decrease in necrotic core, but was not associated with a decrease in percentage atheroma volume. On the contrary, statin use was only associated with a decrease in percentage atheroma volume.
authors: Thoraxcenter, Erasmus MC, Ba583, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. h.garciagarcia@erasmusmc.nl
authors: Héctor M
authors: HM
authors: García-García
authors: Volker
authors: V
authors: Klauss
authors: Nieves
authors: N
authors: Gonzalo
authors: Scot
authors: S
authors: Garg
authors: Yoshinobu
authors: Y
authors: Onuma
authors: Christian W
authors: CW
authors: Hamm
authors: William
authors: W
authors: Wijns
authors: Jennifer
authors: J
authors: Shannon
authors: Patrick W
authors: PW
authors: Serruys
references: Circulation. 2000 Aug 1;102(5):531-8
references: 10920065
references: JAMA. 2004 Nov 10;292(18):2217-25
references: 15536108
references: Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2523-9
references: 16960105
references: Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1010-9
references: 3904565
references: N Engl J Med. 1997 May 1;336(18):1276-82
references: 9113930
references: Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1266-71
references: 15142859
references: Circulation. 1992 Jan;85(1 Suppl):I19-24
references: 1728500
references: J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8
references: 16631505
references: Circulation. 2008 Jul 29;118(5):482-90
references: 18625893
references: J Am Coll Cardiol. 2008 Apr 29;51(17):1632-41
references: 18436114
references: Int J Obes Relat Metab Disord. 2004 Aug;28(8):1018-25
references: 15197408
references: J Am Coll Cardiol. 2007 Sep 4;50(10):940-9
references: 17765120
references: J Am Coll Cardiol. 2007 Apr 10;49(14):1546-51
references: 17418293
references: Nat Med. 2008 Oct;14(10):1059-66
references: 18806801
references: Arterioscler Thromb Vasc Biol. 2000 May;20(5):1262-75
references: 10807742
references: Lancet. 2005 Nov 5;366(9497):1640-9
references: 16271645
references: Circulation. 2008 Sep 9;118(11):1172-82
references: 18765397
references: N Engl J Med. 2004 Sep 23;351(13):1285-95
references: 15385655
references: Lancet. 2004 Sep 11-17;364(9438):937-52
references: 15364185